Safety and Immunogenicity of a ChAd155-Vectored Respiratory Syncytial Virus Vaccine in Infants 6–7 Months of age: A Phase 1/2 Randomized Trial
Xavier Sáez‐Llorens(Hospital del Niño), Nicolas Vanhoutte(GlaxoSmithKline (Belgium)), Leszek Szenborn(Wroclaw Medical University), James D. Campbell(Centers for Disease Control and Prevention), Kathia Luciani, Guido Castelli Gattinara(Bambino Gesù Children's Hospital), Vanja Nikic, Jerzy Brzostek, Tirza De León, Damien Friel(GlaxoSmithKline (Belgium)), Roderick McPhee, Fernando Baquero‐Artigao(Instituto de Salud Carlos III), Henryk Szymański, Mika Rämet(Tampere University), François D. Boucher(Centre hospitalier universitaire de Québec), Ener Çağrı Dinleyici(Eskişehir Osmangazi Üniversitesi Tıp Fakültesi Hastanesi), Ignacio Salamanca de la Cueva(Instituto Hispalense de Pediatria), Thanyawee Puthanakit(Chulalongkorn University), Cristina Epalza(Universidad Complutense de Madrid), Miguel Ángel Marín Gabriel(Hospital Universitario Puerta de Hierro Majadahonda), Ilse Dieussaert, Ximena Norero(Hospital del Niño), Federico Martinón‐Torres(Complejo Hospitalario Universitario de Santiago), Tolga İ̇nce(Dokuz Eylül University), Saul N. Faust(University Hospital Southampton NHS Foundation Trust), Bruce Tapiéro(Centre Hospitalier Universitaire Sainte-Justine), Evan J. Anderson(Emory University), Ernest Kuchar(Medical University of Warsaw), Benhur Şirvan Çetin(Erciyes University), Javier Díez‐Domingo, Marisa Márcia Mussi‐Pinhata(Universidade de São Paulo), Yingjun Zhou(Central South University), Joanne M. Langley(Dalhousie University), Antonio López, Eduardo López‐Medina(Universidad del Valle), José Tomás Ramos Amador(Universidad Complutense de Madrid), J.M. Merino Arribas(Hospital Universitario de Burgos), Jorge Pinto(Universidade Federal de Minas Gerais), Wenji Pu(GlaxoSmithKline (United States)), Mercedes Macías-Parra(Instituto Nacional de Pediatria), Sonia Stoszek(GlaxoSmithKline (United States))
Cited by 13
Related Papers
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
|New England Journal of Medicine|2015|3.4k
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Children
|New England Journal of Medicine|2015|1.9k